SLG
69
3
ALLE
46
2
HIG
62
8
CVS
52
13
ROK
54
12
URBN
54
-2
MHK
52
7
WBA
48
-5
ADSK
70
5
CINF
50
10
NWL
52
-2
AES
38
-6
DGX
44
8
AKAM
61
7
AZO
56
6
NOV
53
11
JCI
56
11
EOG
55
6
AIZ
76
22
CHD
42
-3
SLG
69
3
ALLE
46
2
HIG
62
8
CVS
52
13
ROK
54
12
URBN
54
-2
MHK
52
7
WBA
48
-5
ADSK
70
5
CINF
50
10
NWL
52
-2
AES
38
-6
DGX
44
8
AKAM
61
7
AZO
56
6
NOV
53
11
JCI
56
11
EOG
55
6
AIZ
76
22
CHD
42
-3
Financhill
Back

Range Cancer Therapeutics ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison

Buy
63

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.58
Seasonality Move:
8.86%
Sell
49

FTXH
First Trust Nasdaq Pharmaceuticals ETF

Last Price:
28.34
Seasonality Move:
6.3%
Buy
63
Range Cancer Therapeutics ETF (CNCR) is a Buy

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $15.59. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a Sell

Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.52. The Score for FTXH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $15.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.

FTXH Stock Price Chart

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

  • The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing selling pressure, which indicates risk of future bearish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 59.34 Buy
Chaikin Money Flow: -127 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.63 - 15.23) Buy
Bollinger Bands (100): (14 - 15.38) Buy

FTXH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 51.08 Buy
Chaikin Money Flow: -2412 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.2 - 28.68) Buy
Bollinger Bands (100): (27.77 - 29.13) Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.03 Buy
20-day SMA: 15 Buy
50-day SMA: 15.01 Buy
200-day SMA: 15.06 Buy
8-day EMA: 15.09 Buy
20-day EMA: 15.01 Buy
50-day EMA: 14.94 Buy
200-day EMA: 14.59 Buy

FTXH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.3 Buy
20-day SMA: 28.44 Buy
50-day SMA: 28.76 Sell
200-day SMA: 27.79 Buy
8-day EMA: 28.33 Buy
20-day EMA: 28.42 Buy
50-day EMA: 28.53 Sell
200-day EMA: 27.85 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Trust Nasdaq Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):